Atlas Trials

GeneCradle Inc

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GeneCradle Inc

RecordFirmDate
Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD) (NCT07173933)GeneCradle Inc2025-10-01
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III (NCT06971094)GeneCradle Inc2025-05-27
Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis (NCT05860569)GeneCradle Inc2024-09-20
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients (NCT06421831)GeneCradle Inc2024-05-10
Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug (NCT06391736)GeneCradle Inc2024-04-19
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients (NCT05901987)GeneCradle Inc2023-08-01
Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug (NCT05793307)GeneCradle Inc2023-06-02
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients (NCT05824169)GeneCradle Inc2023-02-25

Track GeneCradle Inc automatically

Every clearance here is in the API, with alerts when new ones post.